Literature DB >> 34432917

Monte Carlo Simulations Reveal New Design Principles for Efficient Nanoradiosensitizers Based on Nanoscale Metal-Organic Frameworks.

Ziwan Xu1, Kaiyuan Ni1, Jianming Mao1, Taokun Luo1, Wenbin Lin1,2.   

Abstract

Nanoscale metal-organic frameworks (nMOFs) have recently been shown to provide better radiosensitization than solid nanoparticles (NPs) when excited with X-rays. Here, a Monte Carlo simulation of different radiosensitization effects by NPs and nMOFs using a lattice model consisting of 3D arrays of nanoscale secondary building units (SBUs) is reported. The simulation results reveal that lattices outperform solid NPs regardless of radiation sources or particle sizes via enhanced scatterings of photons and electrons within the lattices. Optimum dose enhancement can be achieved by tuning SBU size and inter-SBU distance.
© 2021 Wiley-VCH GmbH.

Entities:  

Keywords:  Monte Carlo simulations; metal-organic frameworks; nanoparticles; radiosensitizers

Year:  2021        PMID: 34432917      PMCID: PMC8492529          DOI: 10.1002/adma.202104249

Source DB:  PubMed          Journal:  Adv Mater        ISSN: 0935-9648            Impact factor:   32.086


  46 in total

1.  The effect of sedimentation and diffusion on cellular uptake of gold nanoparticles.

Authors:  Eun Chul Cho; Qiang Zhang; Younan Xia
Journal:  Nat Nanotechnol       Date:  2011-04-24       Impact factor: 39.213

2.  BSA-bioinspired gold nanorods loaded with immunoadjuvant for the treatment of melanoma by combined photothermal therapy and immunotherapy.

Authors:  Benqing Zhou; Jun Song; Meng Wang; Xin Wang; Jielin Wang; Eric W Howard; Feifan Zhou; Junle Qu; Wei R Chen
Journal:  Nanoscale       Date:  2018-11-29       Impact factor: 7.790

3.  Near-infrared emitting radioactive gold nanoparticles with molecular pharmacokinetics.

Authors:  Chen Zhou; Guiyang Hao; Patrick Thomas; Jinbin Liu; Mengxiao Yu; Shasha Sun; Orhan K Öz; Xiankai Sun; Jie Zheng
Journal:  Angew Chem Int Ed Engl       Date:  2012-09-07       Impact factor: 15.336

4.  Tungsten anode spectral model using interpolating cubic splines: unfiltered x-ray spectra from 20 kV to 640 kV.

Authors:  Andrew M Hernandez; John M Boone
Journal:  Med Phys       Date:  2014-04       Impact factor: 4.071

5.  First-in-Human Study Testing a New Radioenhancer Using Nanoparticles (NBTXR3) Activated by Radiation Therapy in Patients with Locally Advanced Soft Tissue Sarcomas.

Authors:  Sylvie Bonvalot; Cécile Le Pechoux; Thierry De Baere; Guy Kantor; Xavier Buy; Eberhard Stoeckle; Philippe Terrier; Paul Sargos; Jean Michel Coindre; Nathalie Lassau; Rafik Ait Sarkouh; Mikaela Dimitriu; Elsa Borghi; Laurent Levy; Eric Deutsch; Jean-Charles Soria
Journal:  Clin Cancer Res       Date:  2016-10-06       Impact factor: 12.531

Review 6.  Nanoparticle-based theranostic agents.

Authors:  Jin Xie; Seulki Lee; Xiaoyuan Chen
Journal:  Adv Drug Deliv Rev       Date:  2010-08-04       Impact factor: 15.470

7.  Nanoscale radiotherapy with hafnium oxide nanoparticles.

Authors:  Laurence Maggiorella; Gilles Barouch; Corinne Devaux; Agnès Pottier; Eric Deutsch; Jean Bourhis; Elsa Borghi; Laurent Levy
Journal:  Future Oncol       Date:  2012-09       Impact factor: 3.404

Review 8.  Chemical radiosensitizers for use in radiotherapy.

Authors:  P Wardman
Journal:  Clin Oncol (R Coll Radiol)       Date:  2007-05-02       Impact factor: 4.126

9.  Nanoscintillator-mediated X-ray inducible photodynamic therapy for in vivo cancer treatment.

Authors:  Hongmin Chen; Geoffrey D Wang; Yen-Jun Chuang; Zipeng Zhen; Xiaoyuan Chen; Paul Biddinger; Zhonglin Hao; Feng Liu; Baozhong Shen; Zhengwei Pan; Jin Xie
Journal:  Nano Lett       Date:  2015-03-12       Impact factor: 11.189

10.  Passive tumor targeting of renal-clearable luminescent gold nanoparticles: long tumor retention and fast normal tissue clearance.

Authors:  Jinbin Liu; Mengxiao Yu; Chen Zhou; Shengyang Yang; Xuhui Ning; Jie Zheng
Journal:  J Am Chem Soc       Date:  2013-03-22       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.